PATENT CLAIM ANALYSIS

Application Number: 15968074
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["514", "101000"]

Abstract:
Methods and compounds are disclosed for treating a disease or condition by inhibiting PSMA (Prostate Specific Membrane Antigen) using prodrugs of 2-PMPA.

Claim (Index 46):
A pharmaceutical composition comprising a compound of  claim 47  and a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15502105', '15502009', '15885258', '15385490', '15795906']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6818361139390787
- 35 USC 102 Novelty (BERT): 0.5815433316658415
- Combined Prediction Score: 0.671806835711755
- Mean Citation Score: 288.05655399999995
- Max Citation Score: 531.9182
- Similarity Product: 354.48113968716865

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test